Data gathered: November 25
AI Stock Analysis - 10X Genomics (TXG)
Analysis generated October 11, 2024. Powered by Chat GPT.
10X Genomics is a biotechnology company that specializes in advanced genomics research technologies and products. Their innovative solutions are utilized widely within the scientific and medical communities for single-cell analysis, spatial gene expression, and immune profiling, thereby facilitating breakthroughs in research and diagnostics. The company’s technology is at the forefront of genomics, pushing the boundaries of possibilities in understanding concerning complex diseases and biological mysteries.
Stock Alerts - 10X Genomics (TXG)
 |
10X Genomics | November 25 Price is up by 5.2% in the last 24h. |
|
10X Genomics | November 22 Price is up by 6.3% in the last 24h. |
|
10X Genomics | November 19 Employee Rating is up by 2.8% over the last month. |
|
10X Genomics | November 15 Price is down by -5% in the last 24h. |
Alternative Data for 10X Genomics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 56 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 237,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 14 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 560 | Sign up | Sign up | Sign up |
| Facebook Followers | 13,578 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,493 | Sign up | Sign up | Sign up |
| Twitter Followers | 28,970 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 6,210 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 65 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,190 | Sign up | Sign up | Sign up |
About 10X Genomics
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific.
| Price | $15.65 |
| Target Price | Sign up |
| Volume | 348,210 |
| Market Cap | $1.73B |
| Year Range | $13.18 - $38 |
| Dividend Yield | 0% |
| Analyst Rating | 46% buy |
| Industry | Biotechnology |
In the news
 |
10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right NowNovember 19 - Yahoo |
 |
Venturi Wealth Management LLC Boosts Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)November 16 - ETF Daily News |
|
Wealth Enhancement Advisory Services LLC Acquires 10,935 Shares of 10x Genomics, Inc. (NASDAQ:TXG)November 9 - ETF Daily News |
 |
Barclays Cuts 10x Genomics (NASDAQ:TXG) Price Target to $19.00November 4 - ETF Daily News |
 |
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their ForecastsOctober 31 - Yahoo |
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), 10x Genomics (TXG) and Bicycle Therapeutics (BCYC)October 31 - TipRanks |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 152M | 45M | 106M | -36M | -40M | -0.300 |
| Q2 '24 | 153M | 49M | 104M | -38M | -40M | -0.320 |
| Q1 '24 | 141M | 48M | 93M | -60M | -56M | -0.500 |
| Q4 '23 | 184M | 68M | 116M | -49M | -45M | -0.410 |
| Q3 '23 | 154M | 58M | 96M | -93M | -90M | -0.790 |
Insider Transactions View All
| McAnear Justin J. filed to sell 143,242 shares at $22.5. August 26 '24 |
| Hindson Benjamin J. filed to sell 345,704 shares at $22.5. August 26 '24 |
| Saxonov Serge filed to sell 882,467 shares at $22.5. August 26 '24 |
| Hindson Benjamin J. filed to sell 350,055 shares at $24.3. May 23 '24 |
| Saxonov Serge filed to sell 889,641 shares at $24.3. May 23 '24 |
Similar companies
Read more about 10X Genomics (TXG) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of 10X Genomics?
The Market Cap of 10X Genomics is $1.73B.
What is the current stock price of 10X Genomics?
Currently, the price of one share of 10X Genomics stock is $15.65.
How can I analyze the TXG stock price chart for investment decisions?
The TXG stock price chart above provides a comprehensive visual representation of 10X Genomics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling 10X Genomics shares. Our platform offers an up-to-date TXG stock price chart, along with technical data analysis and alternative data insights.
Does TXG offer dividends to its shareholders?
As of our latest update, 10X Genomics (TXG) does not offer dividends to its shareholders. Investors interested in 10X Genomics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of 10X Genomics?
Some of the similar stocks of 10X Genomics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.